XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES                
Net loss   $ (2,037,819) $ (2,646,172) $ (1,794,060) $ (2,032,751) $ (6,369,407) $ (5,403,368)  
Loss from discontinued operations, net of tax           (100,000)  
Loss from continuing operations   (2,037,819)   (1,794,060)   (6,369,407) (5,303,368)  
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:                
Stock-based compensation           269 118,945  
Change in fair value of warrant liabilities           93,148 (361,137)  
Change in fair value of derivative liabilities     495,693   321,080  
Gain on voluntary conversion of convertible debt           (56,010)  
Legal expenses deducted from issuance of converftible debt           20,000  
Issuance of common stock to consultant           325,635  
Provision for credit losses of short-term note receivable           (99,000) $ 360,000
Accrued interest on short-term note receivable           (428,915) (48,082)  
Amortization of penalty on promissory note           635,607  
Loss on monthly redemptions of convertible debt into common stock       208,852  
Accretion of discount on convertible debt           514,028  
Loss on issuance of convertible debt           91,943 358,279  
Gain on change in fair value of derivative liabilities            
Loss on change in fair value of convertible debt   197,667     159,793  
Fair value of warrant modification for professional services           12,036  
Changes in operating assets and liabilities:                
Prepaid expenses and other assets           1,156,128 554,685  
Accounts payable           (285,841) (584,537)  
Accrued expenses and other current liabilities           (128,347) 207,249  
Net cash used in operating activities           (4,828,985) (4,057,980)  
CASH FLOWS FROM INVESTING ACTIVITIES:                
Issuance of short-term note receivable           (1,809,500) (1,250,000)  
Net cash provided by investing activities - discontinued operations           350,000  
Net cash used in investing activities           (1,809,500) (900,000)  
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from the issuance of convertible debt           200,000 1,475,000  
Net Proceeds from issuance of common and preferred shares in private placement           41,911,544  
Proceeds from issuance of common shares and prefunded warrants in public offering $ 6,800,000         3,053,348  
Repayment of convertible debt           (132,000)  
Repayment of promissory notes           (1,033,500) (2,000,000)  
Proceeds from warrant exercises           415,981  
Proceeds from issuance of promissory notes           3,295,000 2,000,000  
Net cash provided by financing activities - continuing operations           44,241,044 4,944,329  
Net cash provided by financing activities - discontinued operations            
Net cash provided by financing activities           44,241,044 4,944,329  
Net change in cash and cash equivalents           37,602,558 (13,651)  
Cash and cash equivalents - beginning of period     $ 1,174,608   $ 401,803 1,174,608 401,803 401,803
Cash and cash equivalents- end of period $ 38,777,166 $ 38,777,166   $ 388,152   38,777,166 388,152 $ 1,174,608
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION                
Interest           61,020  
Taxes           7,864  
NONCASH FINANCING AND INVESTING ACTIVITIES:                
Voluntary conversion of convertible debt into common stock           735,083  
Monthly redemption of convertible debt into common stock           903,329  
Deemed dividend arising from warrant down-round provision           867,796 87,604  
Exchange of derivative liability for warrant and convertible debt           675,625  
Issuance of warrants to placement agent           5,340,491  
Issuance of common stock for the conversion of Series A-2 preferred shares           $ 5,057,361